Bracelet may help predict dementia-related agitation
By
Alicia Lasek
Oct 26, 2019
A location-monitoring bracelet developer has received an NIH grant to study whether its device can detect agitation in seniors with dementia.
Study evaluates heart failure device
May 03, 2017
2breathe Technologies and its U.S. subsidiary Resperate Inc. have announced the publication of an article evaluating its hypertension treatment device, RESPeRATE.
Griffin American acquires Trilogy Health Services for $1.13B
Sep 22, 2015
Griffin American Healthcare REIT III Inc. is acquiring Trilogy Health Services for $1.125 billion in one of the sector’s largest transactions of the year.
Cole hired as VP of marketing at nora
Jul 16, 2015
Tim Cole has been selected to fill the position of vice president of marketing at nora systems, Inc., a manufacturer of commercial floor coverings.
Gentell’s Fastcare now includes QAPI reporting
Jan 06, 2015
Gentell Inc. has announced its Fastcare wound documentation and ordering now includes Quality Assurance Performance Improvement reporting capabilities.
PointRight launches new survey tool for skilled care facilities
Oct 24, 2012
PointRight Inc. recently launched Survey Insights, an analytics-driven tool that skilled nursing facilities can use to better prepare for inspections.
Sun acquires Harborside in $350 million deal
By
Haymarket Media
Oct 24, 2006
Sun Healthcare Group Inc. will acquire Harborside Healthcare Corp. from Investcorp International, an investment firm, for approximately $350 million in cash.
Stress? Resolve? Hope? You can feel it in their voices
By
James M. Berklan
Oct 15, 2021
Today, for the first time at mcknights.com, you can read about and HEAR about agency staffing and other key issues straight from providers’ mics.
Lifespace Communities appoints Nicholas Harshfield as CFO
By
Lois A. Bowers
May 20, 2020
Nicholas “Nick” Harshfield has been appointed chief financial officer of West Des Moines, IA-based Lifespace Communities, effective July 1.
Positive results for drug to treat Alzheimer’s aggression
Dec 15, 2015
Amarantus Bioscience Holdings Inc. has released positive data for Eltoprazine in a Phase 2 clinical trial of elderly patients with Alzheimer’s dementia who are aggressive.